Latest News

Welcome to the Alfred Research Alliance news hub. To catch up on the news from our Alliance members, please click on the links below:

Baker Heart and Diabetes Institute

Around the Precinct: 28 May 2020

A new report sheds light on diabetes risks and the precinct acknowledges Reconciliation Week – this week at the Alfred Research Alliance. Baker Heart and Diabetes Institute Diabetes dramatically increases dementia risk, doubles chance of some cancers Australians living with type 2 diabetes have a 60 per cent higher chance of developing dementia than those without… Read More

First human trial for COVID-19 vaccine in Southern Hemisphere begins at Alfred Research Alliance

Two Alliance members, Nucleus Network and 360biolabs, are facilitating the first human trial of a COVID-19 vaccine developed by US biotech company Novavax. In the race to find treatments and solutions for the COVID-19 pandemic, there are currently more than 100 coronavirus vaccines in development around the world – but only 10 have made it… Read More

Around the Precinct: 21 May 2020

How lockdown has influenced drinking habits, celebrating NHMRC grants, and the impact of COVID-19 on the Melbourne drug market – this week at the Alfred Research Alliance. Alfred Health Lockdown leads to spike in drinking While Victorians were locked down under stage 3 restrictions, alcohol sales increased 34% compared to the same time last year…. Read More

$30m+ in NHMRC Investigator Grants for Alfred Research Alliance

$30m+ in NHMRC Investigator Grants for Alfred Research Alliance

Member organisations from the Alfred Research Alliance have received a total of more than $30 million in the latest round of National Health and Medical Research Council (NHMRC) Investigator Grants, announced yesterday. The Investigator Grant scheme is the largest of the NHMRC’s funding schemes, and aims to support the research program of outstanding investigators at… Read More